{"entity":{"id":"kissei","kind":"company","name":"Kissei Pharmaceutical","aka":["Kissei Pharmaceutical Co., Ltd.","キッセイ薬品工業"],"tldr":"Kissei is a Japanese pharmaceutical company from Matsumoto, founded in 1946, whose in-licensed haematology and oncology products go through the Japanese phase 3 trials it leads.","summary":"Kissei Pharmaceutical Co., Ltd., headquartered in Matsumoto, Nagano, and listed in Tokyo, develops and markets prescription medicines in urology, nephrology and rare diseases, and in-licenses haematology and oncology products for the Japanese market, running the domestic phase 3 trials needed for approval. ClinicalTrials.gov lists Kissei as lead sponsor of phase 3 cancer trials.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://www.kissei.co.jp"},{"label":"ClinicalTrials.gov: trials led by Kissei Pharmaceutical Co., Ltd.","url":"https://clinicaltrials.gov/search?lead=Kissei%20Pharmaceutical%20Co.%2C%20Ltd."},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q11296797"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Matsumoto","country":"JP","companyType":"pharma","website":"http://www.kissei.co.jp","founded":1946,"stage":"public","investors":[],"funding":[]},"route":"/companies/kissei/","neighbours":{"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}